DX-8951f in Treating Patients With Metastatic Stomach Cancer

Completed · Phase 2

Conditions studied: Esophageal Cancer, Gastric Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of exatecan mesylate in treating patients who have metastatic stomach cancer.

Key facts

Study ID

NCT00017212

Run by

Daiichi Sankyo

Starts

2001-04-01

Expected to finish

2003-09-01

Last updated by the study team

2012-05-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Pacific Shores Medical Group — Long Beach, California, United States
• Rocky Mountain Cancer Centers — Denver, Colorado, United States
• Simmons Cancer Center - Dallas — Dallas, Texas, United States
• University of Texas - MD Anderson Cancer Center — Houston, Texas, United States
• Cancer Therapy and Research Center — San Antonio, Texas, United States
• Cancer Care Ontario-Hamilton Regional Cancer Centre — Hamilton, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.